Success Stories from Our Patients
In May 2013, Joe Weber had just dropped his son off at Logan International Airport in Boston and was driving back to Connecticut when he decided to stop for a bite to eat. Before continuing his two-hour trip home, he visited the restroom and noticed an exceptional amount of blood in his urine.
As part of a groundbreaking clinical trial, Peter Ehmer received treatment for his diagnosis of stage III bladder cancer. Prior to this, he had received three months of chemotherapy, had surgery to remove his bladder and prostate and participated in a clinical trial. While on this trial, two of his lymph nodes continued to grow.
Genetic profiling of renal tumors is a complex process, but it provides a crucial window into the composition – and potential treatment – of a tumor. Dr. Brian Shuch believes such profiling can guide the decision to monitor a lesion or perform surgery to remove the lesion or entire kidney. His patient, Dr. Jerome Serling, can attest.
At her appointment with Dr. Patrick Kenney, Tammy learned that she had cancer in her right kidney that was extending into the inferior vena cava, the largest vein in the body, and up into her heart.
After two and a half years of consulting with specialists, the Andersen family was at their wit’s end in trying to help their young son resolve his bladder pain and incontinence. But after meeting with Dr. Israel Franco, Director of Yale’s Pediatric Bladder & Continence Program (pictured left), he devised a non-invasive treatment approach that transformed their lives.
It was during a routine screening that I was diagnosed with stage II prostate cancer. I was in my late 60s and felt fine, despite my diagnosis. Not having been sick since I was 9 years old, I was in denial at first and thought that if everyone just left me alone I could have at least another ten good years.
My PSA had been high for awhile so my doctor recommended I see a urologist. A biopsy was performed and at the age of 54 I was diagnosed with prostate cancer. Without my routine physicals I probably wouldn’t be alive today. We were able to catch the cancer early, and that made all the difference.
When Tom Regan learned that he had prostate cancer, it brought back memories of his father, who 20 years before had lost his life to the disease. Tom assumed that he was destined for the same fate.
Matthew Fried was twenty-two years old when he was diagnosed with stage I testicular cancer. He had just graduated college and was looking forward to beginning his Masters Degree in Music Performance at Yale University.